Chek Diagnostics is an innovative point-of-care medical device manufacturer that partners with clinicians to improve the overall health of patients. The company’s full suite of handheld, highly-accurate, fast, and economical diagnostic devices empowers the medical community to quickly measure a patient’s cholesterol (lipids) and glucose results, as well as provide ongoing chronic disease management.
The company’s CardioChek® products have screened more than 100 million patients worldwide. The A1CNow® product line works to enable people to lead healthier lives through ongoing management of diabetes. These two diagnostic product lines have natural synergies. Additional product lines include a variety of single and combination tests for lipids (cholesterols), glucose, and ketones, as well as the CardioChek Health Risk Assessment (HRA) software package.